{
    "id": 29258,
    "fullName": "BAIAP2L1 - BRAF",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BAIAP2L1-BRAF results from the fusion of BAIAP2L1 and BRAF (PMID: 26892443), and has not been biochemically characterized, however, due to the effects of other BRAF fusions that result in loss of the BRAF CR1 domain and retention of the protein kinase domain (PMID: 23890088, PMID: 12781369), is predicted to result in a gain of function. BAIAP2L1-BRAF has been identified in spitzoid melanoma (PMID: 26892443), and non-small cell lung cancer (PMID: 30257958).",
            "references": [
                {
                    "id": 14743,
                    "pubMedId": 12781369,
                    "title": "Raf proteins and cancer: B-Raf is identified as a mutational target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12781369"
                },
                {
                    "id": 12495,
                    "pubMedId": 30257958,
                    "title": "Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30257958"
                },
                {
                    "id": 13842,
                    "pubMedId": 26892443,
                    "title": "The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26892443"
                },
                {
                    "id": 3413,
                    "pubMedId": 23890088,
                    "title": "Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23890088"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 55971,
        "geneSymbol": "BAIAP2L1",
        "terms": [
            "BAIAP2L1",
            "IRTKS"
        ]
    },
    "variant": "BAIAP2L1 - BRAF",
    "createDate": "01/29/2019",
    "updateDate": "10/17/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 15835,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with non-small cell lung cancer harboring an EGFR exon 19 deletion developed resistance to combined Tagrisso (osimertinib) and Gemzar (gemcitabine) treatment and was found to have gained a BAIAP2L1-BRAF fusion (PMID: 30257958).",
            "molecularProfile": {
                "id": 31252,
                "profileName": "BAIAP2L1 - BRAF EGFR exon 19 del"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 12495,
                    "pubMedId": 30257958,
                    "title": "Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30257958"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31252,
            "profileName": "BAIAP2L1 - BRAF EGFR exon 19 del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}